ED, Forecasting & Value & Access Analytics

Compensation Data

The base salary range for this position is $262,400 to $393,600.   The position may be eligible for a role specific discretionary bonus, relocation, and/or other compensation elements.  We continuously review market data and may adjust salary ranges as needed in the future.  Actual compensation will be based on job-related factors such as skills, experience, and qualifications, and other factors permitted by law. For an overview of our benefits please click here.

Description

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides an opportunity for all employees to collaborate internationally, offering visibility and the opportunity to directly contribute to the company's success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.

The Executive Director, Forecasting and Value & Access (V&A) Analytics serves as the enterprise leader responsible for overseeing the translation of complex market, customer, payer, health system, access, and business dynamics into actionable forecasts, insights, scenarios, and recommendations that inform Human Pharma's most critical strategic and operational decisions. This role serves as a key thought partner to Commercial, V&A, Finance, Patient Excellence, Medicine, and Customer Engagement & Transformation (CE&T) leadership, ensuring decisions are grounded in a comprehensive understanding of future market performance, business risk, access dynamics, and growth opportunities.

As the senior leader responsible for forecasting and V&A analytics team, the Executive Director (ED) drives enterprise alignment around planning assumptions, performance expectations, and strategic scenarios that influence portfolio strategy, investment prioritization, resource allocation, launch planning, lifecycle management, financial planning, and market access strategy. This role ensures leaders have a forward-looking understanding of business performance and provides objective, analytically rigorous perspectives on evolving market conditions, competitive threats, reimbursement dynamics, customer behavior, and portfolio opportunities to improve decision quality and organizational effectiveness.

The position establishes the vision, governance, standards, methodologies, and operating model for Forecasting and Value & Access Analytics while building organizational capabilities that support increasingly sophisticated decision-making. The ED provides leadership and oversight for data-modeling capabilities, ensuring the underlying analytical frameworks, data structures, assumptions, and methodologies support scalable, accurate, and decision-ready forecasting and market access insights. The ED partners closely with Commercial, Value & Access, Finance, Analytics, AI & Data, Digital Products, Platforms, & Solutions, and global stakeholders to continuously advance forecasting and access-analytics capabilities, enabling the organization to scale, modernize, and make faster, more informed business decisions in an increasingly complex healthcare environment.

As Boehringer moves to an AI-first operating model, the ED leads the transformation of forecasting from a manual, spreadsheet- and vendor-intensive process into an AI-native, platform-based capability — one unified source of inputs and assumptions, real-time scenario modeling, and near real-time, decision-ready outputs, delivered in close partnership with the AI & Data organization.

This position is based in Ridgefield, CT.

Duties & Responsibilities

• Partner with Commercial, V&A, Finance, Marketing, Sales, Patient Excellence, Medicine, and Customer Engagement & Transformation (CE&T) leaders to define the integrated forecasting and Value & Access Analytics agenda.
• Ensure forecasting, payer and health system analytics, formulary coverage insights, reimbursement and access performance analytics, copay analytics, and pull-through measurement are aligned to the most critical business priorities and decision needs.
• Establish priorities, governance, and resource allocation across the function to ensure analytical efforts focus on the highest-value business questions and strategic opportunities.
• Translate evolving enterprise and therapeutic area priorities into a clear roadmap for Forecasting and V&A Analytics capabilities.
• Oversee the development, governance, and communication of forecast assumptions, models, scenarios, and outputs that support commercial planning, financial planning, production planning, portfolio management, and enterprise decision-making.
• Ensure forecasting approaches appropriately reflect market dynamics, access and reimbursement changes, competitive activity, pipeline evolution, launch readiness, lifecycle events, and other factors impacting performance.
• Challenge assumptions, validate methodologies, and guide the definition and quantification of key business risks and opportunities.
• Ensure forecasts move beyond performance reporting and provide meaningful forward-looking perspectives that support proactive business action and resource allocation decisions.
• Reduce the time from data availability to decision-ready forecast by driving AI-assisted workflows, automated inputs and assumptions capture, and self-service scenario modeling, while preserving a human-in-the-loop model.
• Partner with Value & Access, Contracting, Trade Relations, Brand teams, and other stakeholders to ensure payer and health system analytics are translated into meaningful business insights and incorporated into planning assumptions, performance evaluation, and strategic decisions.
• Oversee the integration of formulary coverage insights, reimbursement and access performance analytics, copay analytics, and pull-through measurement into a unified understanding of market performance and future opportunity.
• Ensure analytics are interpreted within the broader commercial context and translated into implications for access strategy, portfolio planning, resource allocation, launch preparation, customer engagement, and performance optimization.
• Hold data providers and vendors accountable for the quality, timeliness, and traceability of input feeding forecasts and access analytics, partnering with data governance bodies (e.g., the Patient Data Council) to ensure decisions rest on a single, trusted version of the truth.
• Own the synthesis of forecasting, payer/health system analytics, market, competitive, and access signals into clear, integrated insights that answer the "so what / now what" for business leaders. Ensure the function moves beyond reporting and models to deliver a coherent point of view — framing the business question, connecting insights across sources, quantifying implications, and recommending action on strategy, investment, access, and resource allocation.
• Proactively surface emerging risks, opportunities, and performance shifts to Commercial, V&A, Finance, and TA partners ahead of demand, and ensure insights are delivered in near real time and embedded directly into planning and decision cycle.

Requirements

• Bachelor’s Degree required, advanced degree preferred.
• Minimum of twelve (12) years of experience in pharmaceutical industry, life sciences, or equivalent.
• Proven ability to synthesize forecasting, market, competitive, and access analytics into integrated, decision-ready insights and recommendations — framing the business question, articulating implications, and influencing senior stakeholders to act.
• Expertise in pharmaceutical forecasting methodologies, including the utilization of AI and advanced modeling techniques.
• Strong understanding of the U.S. market dynamics, including health systems, reimbursement, co-pay, healthcare policies, and consumer behavior.
• Strong forecasting and analytical skills.
• Strong executive presence and the ability to communicate effectively with leaders across U.S. HP and Global.
• Ability to build relationships with business partners and cultivate a culture of collaboration and partnership.
• Experience building scalable analytical capabilities that utilize industry-leading data and technology.
• Proactive business-partnering mindset, with a track record of anticipating needs, surfacing risks/opportunities, and shaping decisions before requests become urgent or reactive.
• Ability to lead, coach, and develop multidisciplinary teams and build capability in strategic thinking, business partnership, recommendation development, and influential communication.

Eligibility Requirements:

• Must be legally authorized to work in the United States without restriction.
• Must be willing to take a drug test and post-offer physical (if required).
• Must be 18 years of age or older.

Desired Skills, Experience and Abilities

Additional Duties & Responsibilities:

Build a High-Performing Forecasting and Value & Access Analytics Organization

• Ensure the organization is staffed with qualified, highly motivated talent possessing the business, analytical, forecasting, and market access capabilities required to support the evolving needs of Human Pharma.
• Foster a culture that values business acumen, proactive partnership, strategic thinking, data fluency, AI adoption, ownership and accountability for outcomes, recommendation development, and influential communication in addition to technical excellence.
• Coach team members to operate as trusted advisors who understand business priorities, challenge assumptions constructively, anticipate future needs, and translate complex information into clear actions.
• Drive performance management, succession planning, capability development, and continuous improvement to ensure the organization remains aligned with current and future business requirements.
• Adapt organizational capabilities such as forecasting, V&A analytics, digital, and AI-enabled approaches continue to evolve.

Align Financial, Resource, and Operational Priorities Across the Function

• Ensure function goals, resources, budgets, and operating plans remain aligned with Human Pharma, CE&T, and enterprise priorities.
• Allocate resources across forecasting, V&A analytics, strategic initiatives, and emerging business needs to maximize value and organizational impact.
• Continuously assess opportunities to simplify, standardize, automate, and improve forecasting and analytical processes while maintaining compliance, quality, and business relevance.
• Balance immediate business support needs with longer-term capability-building and transformation objectives.

Advance Forecasting and Analytics Capabilities Through Innovation and External Benchmarking:

• Champion the adoption of AI, GenAI, and agentic approaches to forecasting and V&A analytics — partnering with the AI & Data organization as the primary co-owner of shared data products, semantic models, and the forecasting platform — to strengthen the organization's ability to anticipate market, patient, payer, and consumer needs.
• Leverage selective external benchmarking on forecasting practices and emerging innovation trends to inform planning assumptions and the evolution of forecasting and access-analytics capabilities.
• Partner with Data, AI, Digital Products, Platforms, & Solutions, and global counterparts to evaluate and scale new approaches that improve accuracy, efficiency, and decision-relevance.